1. Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial  CNBC
  2. Early Coronavirus Immunity Data Fuel Promise for a Vaccine  Scientific American
  3. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial  The Lancet
  4. Why we might not get a coronavirus vaccine  The Guardian
  5. Early study of Covid-19 vaccine developed in China sees mixed results  STAT
  6. View Full coverage on Google News

Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good newsResearchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news

Early Coronavirus Immunity Data Fuel Promise for a Vaccine - Scientific American

A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal. A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal.

“CanSino reported on its Phase 1 #Covid19 vaccine trial in Lancet. Detail is terrific. Bravo for reporting vaccine data. But the anticipated problem with their viral vector seems indeed to be a problem. Lots of pre-existing immunity to the Ad5 vector. https://t.co/bYhWi1aooh”

Helen Branswell on Twitter: "CanSino reported on its Phase 1 #Covid19 vaccine trial in Lancet. Detail is terrific. Bravo for reporting vaccine data. But the anticipated problem with their viral vector seems indeed to be a problem. Lots of pre-existing immunity to the Ad5 vector. https://t.co/bYhWi1aooh"

“Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers https://t.co/k84WMipusf”

Jeremy Farrar on Twitter: "Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers https://t.co/k84WMipusf"

“Several new findings on coronavirus immunity have scientists feeling more optimistic about the hunt for a Covid-19 vaccine https://t.co/oKOYpJsp1Q via @bopinion”

Ophir Gottlieb on Twitter: "Several new findings on coronavirus immunity have scientists feeling more optimistic about the hunt for a Covid-19 vaccine https://t.co/oKOYpJsp1Q via @bopinion"

“News: Via @TheLancet “The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans...” #COVIDー19”

Major Garrett on Twitter: "News: Via @TheLancet “The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans...” #COVIDー19"

An early-stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early-stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early-stage trials | TheHill

An early-stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early-stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early-stage trials | TheHill

The animal studies have provided new hope that an effective vaccine for humans is possible.The animal studies have provided new hope that an effective vaccine for humans is possible.

Monkeys Protected From COVID-19 With Prototype Vaccines

Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.

Early study of Covid-19 vaccine developed in China sees mixed results

China's COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, has been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans, according to a study published online on Friday by medical journal The Lancet.

China's COVID-19 vaccine trial shows promising results: The Lancet - CGTN

Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19. Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19.

COVID-19 Vaccine Trial Produced ‘Immediate’ Immune Response in Mice - Chinese Researchers - Sputnik International

A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies involved injecting the virus into monkeys, and of those that recovered, they seem to have developed an immunity to the disease.The studies were published on Wednesday, according to Reuters, which [...]A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies [...]

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.

CanSino Biologics coronavirus vaccine human results - Business Insider

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published ...

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

Bloomberg - Are you a robot?

A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.

New review discusses findings on coronavirus immunity

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

Moderna provides cursory glance at first COVID-19 vaccine data

A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2

First successful human trial of Covid-19 vaccine finds it 'safe for use' - Daily Star

Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn’t possible for COVID-19 survivors or for subjects who received vaccine candidates.Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn…

This is the best coronavirus news we’ve seen all month – BGR

Some recent news items offer clues as to how investors will respond when the FDA approves a SARS-CoV-2 vaccine.Some recent news items offer clues as to how investors will respond when the FDA approves a SARS-CoV-2 vaccine.

How a Coronavirus Vaccine Might Move the Stock Market | The Motley Fool

Monkeys that have survived Covid-19 are immune to getting it again, at least initially and several vaccines appear to have the same effectSurviving Covid-19 or receiving preliminary vaccines gives monkeys protective immunity to SARS-CoV-2. Although we don't yet know how long the protection la

Monkeys Gain Immunity From Covid-19 and Potential Vaccines | IFLScience

Hopes for a vaccine against the coronavirus soared today after the first clinical trial of a potential jab found it to be safe, well-tolerated, and able to generate an immune response against the infection.Hopes for a vaccine against the coronavirus soared today after the first clinical trial of a potential jab found it to be safe, well-tolerated, and able to generate an immune response against the infection.

'Important milestone' - Hopes for coronavirus vaccine soar after success of first clinical trial - Independent.ie

[media type="image" id="767881" layout="medium" position="left" caption="1"][/media] Death toll nears 330,000The novel coronavirus has killed at least 328,220 people since the outbreak first emerged in China last December, according to a tally from official

Coronavirus Pandemic: Key Updates | The Daily Star

A Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a good sign, but Dr Peter Hotez says it may not trigger blocking antibodies.A Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a good sign, but Dr Peter Hotez says it may not trigger blocking antibodies.

China's coronavirus vaccine is 'safe' in world's first completed human trial | Daily Mail Online

The studies looked at a prototype vaccine and whether infection with SARS-CoV-2 provides immunity against re-exposureThe studies looked at a prototype vaccine and whether infection with SARS-CoV-2 provides immunity against re-exposure

New studies show monkeys infected with coronavirus develop immunity

Here's the latest from around the world overnight.Here's the latest from around the world overnight.

Coronavirus: Latest on COVID-19 from around the world - Friday, May 22 | Newshub

The world's first coronavirus (Covid-19) vaccine has now been deemed 'safe for human' in a breakthrough study, say researchers at Beijing Institute of Biotechnology in Beijing, ChinaThe world's first coronavirus (Covid-19) vaccine has now been deemed 'safe for human' in a breakthrough study, say researchers at Beijing Institute of Biotechnology in Beijing, China

Potential coronavirus vaccine is 'safe for humans' after tests on 109 adults - World News - Mirror Online

A group of US researchers has found that monkeys once infected with the novel coronavirus did not contract the virus a second time due to the functioning of their immune system.A group of US researchers has found that monkeys once infected with the novel coronavirus did not contract the virus a second time due to the functioning of their immune system.

Study: Monkeys show immunity to coronavirus | NHK WORLD-JAPAN News

Access Denied

Vaccines developed by scientists in the United States have been shown to be effective in protecting monkeys against the coronavirus that causes Covid-19.Researchers from the Beth Israel Deaconess Medical Centre (BIDMC) in Boston, Massachusetts carried out two studies using six DNA vaccine candidatesVaccines developed by scientists in the United States have been shown to be effective in protecting monkeys against the coronavirus that causes Covid-19.Researchers from the Beth Israel Deaconess Medical Centre (BIDMC) in Boston, Massachusetts carried out two studies using six DNA vaccine candidates

Coronavirus: US vaccine protects macaques from Covid-19, studies show

Studies carried out on rhesus macaque monkeys to see whether they develop protective virus immunity.Studies carried out on rhesus macaque monkeys to see whether they develop protective virus immunity.

Monkeys develop virus immunity after infection, vaccine: studies - World - DAWN.COM

Two studies in monkeys have produced some of the first scientific evidence that surviving coronavirus may result in immunity from reinfection and boosted hopes effective human vaccines can be developed. In one of the new studies carried out by researchers in the United States, the results of which were published on Wednesday, nine rhesus macaque monkeys wereTwo studies in monkeys have produced some of the first scientific evidence that surviving coronavirus may result in immunity from reinfection and boosted hopes effective human vaccines can be

Monkeys infected with Covid-19 develop immunity in Harvard studies | London Evening Standard

It's good news first Phase 1 clinical trial has found COVID-19 vaccine to be safe, well-tolerated, and able to generate an immune response against Covid 19 in humans.It's good news first Phase 1 clinical trial has found COVID-19 vaccine to be safe, well-tolerated, and able to generate an immune response against Covid 19 in humans.

First COVID-19 vaccine found safe and effective in human trial: Lancet

It's good news first Phase 1 clinical trial has found COVID-19 vaccine to be safe, well-tolerated, and able to generate an immune response against Covid 19 in humans.It's good news first Phase 1 clinical trial has found COVID-19 vaccine to be safe, well-tolerated, and able to generate an immune response against Covid 19 in humans.

First COVID-19 vaccine found safe and effective in human trial: Lancet

The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus -- a "milestone" in the battle to defeat the deadly bug, a new study found.The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat

Coronavirus vaccine gets positive results in first human trial

Two new studies demonstrate vaccine protection by showing that SARS-CoV-2 infection induced protective immunity against re-exposure in nonhuman primates.Two new studies demonstrate vaccine protection by showing that SARS-CoV-2 infection induced protective immunity against re-exposure in nonhuman primates.

SARS-CoV-2 Prototype Vaccine Protects Macaques

The first Covid-19 vaccine to be tested in humans has been found to be safe, well-tolerated, and able to generate an immune response against the… The first Covid-19 vaccine to be tested in humans has been found to be safe, well-tolerated, and able to generate an immune response against the…

Coronavirus: Cure hope as first ever human trial of a possible vaccine finds that it 'generates immune response within 28 days' | HeraldScotland

Two studies involving testing experimental coronavirus vaccines in monkeys have shown promising results suggestive of immunity and protection against COVID-19. The researchers say that further studies need to be conducted to determine if the same results will be seen in human subjects.Two studies involving testing experimental coronavirus vaccines in monkeys have shown promising results suggestive of immunity and protection against COVID-19. The researchers say that further studies need to be conducted to determine if the same results will be seen in human subjects.

Two Harvard-led Coronavirus Vaccine Trials Conducted on Monkeys Demonstrated Protection and Immunity Against the Virus | Science Times

Here's a review of the latest scientific studies on the SARS-CoV-2 coronavirus, as well as efforts to find treatments and vaccines.Here's a review of the latest scientific studies on the SARS-CoV-2 coronavirus, as well as efforts to find treatments and vaccines.

Corona research round-up: Immunity in monkeys, saliva and breeze; more - SCIENCE News

Two published studies appear to suggest that monkeys who survived COVID-19 developed antibodies that resulted in immunity from reinfection.Two published studies appear to suggest that monkeys who survived COVID-19 developed antibodies that resulted in immunity from reinfection.

One thing that the world didn’t know so far was if an infected person who recovers from the infection is safe from reinfection.One thing that the world didn’t know so far was if an infected person who recovers from the infection is safe from reinfection.

COVID-19 Vaccine Update: Harvard studies show DNA vaccines provide partial immunity and antibodies prevent reinfection - Firstpost

In one of the new studies, researchers infected nine monkeys with Sars-CoV-2, which causes Covid-19. After they recovered, the team exposed them to the virus again and the animals did not get sick.In one of the new studies, researchers infected nine monkeys with Sars-CoV-2, which causes Covid-19. After they recovered, the team exposed them to the virus again and the animals did not get sick.

Covid-19: Two studies indicate reinfection may not happen - world news - Hindustan Times

Science News: Two studies in monkeys published on Wednesday offer some of the first scientific evidence that surviving Covid-19 may result in immunity from reinfectScience News: Two studies in monkeys published on Wednesday offer some of the first scientific evidence that surviving Covid-19 may result in immunity from reinfect

Monkeys infected with Covid-19 develop immunity in studies, a positive sign for vaccines - Times of India